We are live on ! Find out more
KL

KCK Ltd Portfolio holdings

AUM $15.1M
1-Year Est. Return 30.14%
This Fund
S&P 500
This Quarter Est. Return
-16.71%
1 Year Est. Return
+30.14%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.1M
AUM Growth
-$3.22M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SGHT icon
1
Sight Sciences
SGHT
$286M
$15M 99.66%
4,374,975
– –
RNTX
2
Rein Therapeutics
RNTX
$63.1M
$52.1K 0.34%
22,341
– –

Similar funds

LM
Lasry Marc $15.1M AUM 10.39% 1-Year Est. Return
AVM
Avalon Ventures Management La Jolla, California $14.2M AUM 9.35% 1-Year Est. Return
RCMU
Rokos Capital Management (US) New York $14.2M AUM
TPC
Takeda Pharmaceutical Company Tokyo, Japan $16.4M AUM 195.92% 1-Year Est. Return
SI
SQN Investors Menlo Park, California $12.8M AUM
TAC
Twenty Acre Capital Newtown, Pennsylvania $12.4M AUM 49.87% 1-Year Est. Return
DADR
Dynamo Administracao de Recursos Rio De Janeiro, Brazil $18.5M AUM 37.41% 1-Year Est. Return
PM
Pharo Management New York $18.7M AUM

KCK Ltd's Q3 2025 Portfolio in Review

As of Q3 2025, KCK Ltd held 2 positions worth $15.1M, down 18% from $18.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2025: portfolio turnover was 0%. KCK Ltd opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • KCK Ltd's ten largest holdings make up 100% of its $15.1M portfolio in Q3 2025.
  • KCK Ltd opened 0 new positions and closed 0 in Q3 2025.
  • KCK Ltd's portfolio value fell 18% quarter-over-quarter to $15.1M.

Based on KCK Ltd's 13F filing for Q3 2025, filed 14 Oct 2025.